PubMed Randomized trialNAD+ and precursor evidence2021 Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women Human NMN source for metabolic claims while keeping population limits clear
In June, the FDA issued a warning about unapproved GLP-1 drugs, noting that it had logged hundreds of adverse event reports potentially tied to the products
How three receptors work together Each receptor contributes something different to the overall effect: GLP-1 receptor activation: Reduces appetite, slows gastric emptying, and enhances insulin secretion
Liraglutide is effective for weight loss and blood sugar control, but is less potent than newer GLP-1 medications such as semaglutide (Ozempic, Wegovy, and Rybelsus) and tirzepatide (Mounjaro and Zepbound), which provide greater weight loss and better sugar control
Key Advantages: Minimal side effects, promotes natural GH release, no cortisol spike